RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

Ph Gabriel Steg, Shamir R Mehta, J Wouter Jukema, Gregory Y.H. Lip, C Michael Gibson, Frantisek Kovar, Petr Kala, Alberto Garcia-Hernandez, Ronny W Renfurm, Christopher B Granger, RUBY-1 Investigators, Christian Tobias Torp-Pedersen

    151 Citationer (Scopus)

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome'. Sammen danner de et unikt fingeraftryk.

    Medicin og biovidenskab